ETON PHARMACEUTICALS INC. - COMMON STOCK
14.70
30-يوليو-25 08:00:30
15 متأخرة بدقائق
الأسهم
+0.27
+1.87%
نطاق اليوم
14.25 - 14.87
ISIN
N/A
المصدر
NASDAQ
-
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
28 يوليو 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
08 يوليو 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
27 يونيو 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
28 مايو 2025 14:28:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
14 مايو 2025 13:30:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
13 مايو 2025 13:01:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
01 مايو 2025 13:30:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
28 أبريل 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Out-Licenses International Rights to Increlex®
01 أبريل 2025 04:00:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
18 مارس 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
14 مارس 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
04 مارس 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
03 مارس 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
07 فبراير 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
06 فبراير 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
03 يناير 2025 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
20 ديسمبر 2024 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
17 ديسمبر 2024 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
03 ديسمبر 2024 03:50:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
25 نوفمبر 2024 03:50:00 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >